Anti-apoptotic Bcl-2 protein family members are upregulated in various cancers, e.g., chronic lymphocytic leukemia (CLL) [4], diffuse large B-cell lymphoma (DLBCL) [4], but also solid tumors such as prostate cancer [5]. Here, BCL2 is linked to B-cell chronic lymphocytic leukemia.